Skip to main content
    O

    Ocugen Inc (OCGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.76
    -0.02 (-2.11%)

    Market Cap: $262.28M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Ocugen Inc (OCGN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Ocugen (OCGN) has a market cap of $262.28M and an enterprise value of $239.43M. It kept -1367.61% of revenue as net income over the last 12 months. Its share count is up 11.58% from a year earlier.

    Total Valuation

    Enterprise value is 8.71% below the market cap, as cash exceeds debt.

    Market Cap$262.28M
    Enterprise Value$239.43M
    Latest price (Nov 17, 2026)$0.76

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.16% in the quarter ended Sep 30, 2026 and grew 10.43% a year over 2 years.

    Shares Outstanding339.21M
    Shares Change (YoY)+11.58%
    Shares Change (QoQ)+0.16%
    Share Count Growth (2Y CAGR)+10.43%

    Valuation Ratios

    The price to sales ratio is 53.7x. Its year-end P/S ranged from 6.1x to 115.0x from 2020 to 2025.

    P/S Ratio53.7x
    Forward P/S45.3x

    Price Statistics

    The stock is down 36.41% over 52 weeks and trades 16.48% below its 50-day average.

    Beta (1Y)1.76
    52-Week Change-36.41%
    1-Month Change-3.89%
    3-Month Change-48.87%
    6-Month Change-41.79%
    5-Year Change-94.07%
    10-Year Change-99.56%
    Total Return (1Y)-36.41%
    Total Return (5Y CAGR)-36.40%
    Max Drawdown (1Y)-71.67%
    Max Drawdown (3Y)-73.92%
    Sharpe Ratio (1Y)-0.51
    Correlation with SPY (1Y)0.30
    50-Day Average$0.91
    200-Day Average$1.38
    52-Week Range$0.69 to $2.73
    RSI (14 Days)40.5
    Average Volume (20 Days)7.50M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.77x current liabilities.

    Current Ratio0.77x
    Quick Ratio0.77x
    Interest Coverage-4.33x

    Returns and Efficiency

    Return on invested capital is 271.00% over the last 12 months.

    Return on Assets (ROA)-60.48%
    Return on Invested Capital (ROIC)271.00%
    ROA (5Y Average)-90.86%
    Asset Turnover0.06x

    Scores

    OCGN has an Altman Z-Score of -6.61, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-6.61
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $4.78M over the last 12 months is down 11.01% from the 12 months before.

    Revenue$4.78M
    Revenue Growth (YoY)-11.01%
    Gross Profit$4.78M
    Operating Income-$69.03M
    Pretax Income-$65.18M
    Net Income-$65.36M
    EBITDA-$50.16M
    EBIT-$54.55M
    Reported EPS (TTM)-$0.25

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$24.63M
    Total Debt$1.78M
    Net Cash$22.85M
    Net Cash Per Share$0.07
    Working Capital-$27.47M
    Shareholder Equity-$17.68M
    Total Assets$108.06M
    Total Liabilities$125.74M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $211.00K of capital spending, operating cash flow left -$63.90M of free cash flow.

    Operating Cash Flow-$63.69M
    Capital Expenditures$211.00K
    Free Cash Flow-$63.90M
    FCF Per Share-$0.19
    Depreciation and Amortization$5.19M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1444.47%.

    Gross Margin100.00%
    Operating Margin-1444.47%
    Pretax Margin-1363.86%
    Net Margin-1367.61%
    EBITDA Margin-1049.53%
    EBIT Margin-1141.54%
    FCF Margin-1337.16%

    Growth

    Revenue grew 21.05% a year over 3 years.

    Revenue Growth (3Y CAGR)+21.05%
    Revenue Growth (5Y CAGR)+152.50%

    Revenue and profit by year

    Dividends and Yields

    OCGN does not pay a dividend. Its free cash flow yield is -24.90%.

    FCF Yield-24.90%
    Buyback Yield-9.00%
    Shareholder Yield-9.00%

    Stock Splits

    The last split was a 1-for-60 reverse split on Sep 30, 2019.

    Last Split DateSep 30, 2019
    Split TypeReverse split
    Split Ratio1:60

    Peer Position

    Against 6 similar companies, OCGN has the 2nd highest P/S.

    P/S Ratio53.7x vs 8.6x median
    ROIC271.00% vs -42.31% median
    Revenue Growth (Trailing 4 Quarters, YoY)-11.01% vs -78.05% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 28.91% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+28.91%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OCGN

    What is OCGN's market cap?

    Ocugen has a market cap of $262.28M. Its enterprise value, which adds debt and subtracts cash, is $239.43M.

    How many shares of OCGN are outstanding?

    Ocugen has 339.21M shares outstanding. The count is up 11.58% from a year earlier.

    Does OCGN pay a dividend?

    No. Ocugen does not pay a dividend.

    How much debt does OCGN have?

    Ocugen has $1.78M of total debt and $24.63M of cash and equivalents, a net cash position of $22.85M.